Kestra Medical Technologies Financial Statements
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kestra Medical Technologies revenue and earnings
In fiscal 2026, Kestra Medical Technologies generated $95.1 million in revenue, up 59.0% from fiscal 2025, its 2nd consecutive year of revenue growth. Kestra Medical Technologies reported a net loss of $131.6 million, compared with a loss of $113.8 million a year earlier. Gross margin was 51.4% (up from 40.5%) and operating margin -141.6%.
Diluted earnings per share came in at -$2.43. Over the last 2 fiscal years, KMTS's revenue has grown at a 84.9% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Kestra Medical Technologies income statement (annual)
| Fiscal year (USD) | FY 20262026-04-30 | FY 20252025-04-30 | FY 20242024-04-30 |
|---|---|---|---|
| Revenue | 95.13M | 59.81M | 27.81M |
| Revenue growth (YoY) | +59.03% | +115.05% | — |
| Cost of Revenue | 46.26M | 35.60M | 27.45M |
| Gross Profit | 48.86M | 24.21M | 362.00K |
| Operating Expenses | 183.60M | 130.59M | 85.42M |
| Research & Development | 19.48M | 15.65M | 15.49M |
| Selling, General & Admin | 164.12M | 114.94M | 69.94M |
| Operating Income | -134.74M | -106.38M | -85.06M |
| Interest Expense | 7.55M | 7.73M | 6.23M |
| Other Income (Expense) | 2.62M | -2.77M | -2.80M |
| Pretax Income | -131.32M | -113.68M | -94.10M |
| Income Tax | 294.00K | 135.00K | 24.00K |
| Net Income | -131.61M | -113.81M | -94.12M |
| Net Income growth (YoY) | — | — | — |
| EPS (Basic) | -2.43 | -5.13 | -5.07 |
| EPS (Diluted) | -2.43 | -5.13 | -5.07 |
| Shares Outstanding (Basic) | 54.18M | 24.58M | 19.89M |
| Shares Outstanding (Diluted) | 54.18M | 24.58M | 19.89M |
| EBITDA | -126.03M | -98.41M | -73.50M |
| Gross Margin | 51.37% | 40.47% | 130.00% |
| Operating Margin | -141.64% | -177.85% | -305.83% |
| Net Margin | -138.36% | -190.28% | -338.39% |
This table shows 3 annual periods of Kestra Medical Technologies's income statement, from FY 2026 back to FY 2024, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a income statement?